2010 Annual Meeting | Neurologic Intensive Care
09:00 AM - 09:05 AM |
Introduction
Edward M. Manno, MD, FAAN |
|
09:05 AM - 09:35 AM |
Neurological Intensive Care Management of Ischemic Stroke
Daryl R. Gress, MD, FAAN |
|
09:40 AM - 10:10 AM |
Acute Treatment of Intracerebral Hemorrhage
William D. Freeman, MD, FAAN |
|
10:15 AM - 10:45 AM |
Intensive Care Management of Subarachnoid Hemorrhage
Thomas P. Bleck, MD, FAAN |
|
10:50 AM - 11:05 AM |
Break
|
|
11:05 AM - 11:20 AM |
What's New in the Acute Management of Ischemic Stroke
Gene Y. Sung, MD, MPH |
|
11:25 AM - 11:40 PM |
What's New in the Management of Intracerebral Hemorrhage
Stephan A. Mayer, MD |
|
11:45 AM - 12:00 PM |
What's New in the Management of Subarachnoid Hemorrhage
Daryl R. Gress, MD, FAAN |
|
12:00 PM - 12:20 PM |
Discussion
|
|
12:20 PM - 01:30 PM |
Lunch
|
|
01:35 PM - 02:05 PM |
Acute Management of Status Epilepticus
Edward M. Manno, MD, FAAN |
|
02:05 PM - 02:40 PM |
Head Trauma Guidelines and Management of Intracranial Hypertension
Gene Y. Sung, MD, MPH |
|
02:40 PM - 03:15 PM |
Neuromuscular Disease in the Intensive Care Unit
Edward M. Manno, MD, FAAN |
|
03:15 PM - 03:40 PM |
Break
|
|
03:40 PM - 03:55 PM |
What's New in the Management of Status Epilepticus
Thomas P. Bleck, MD, FAAN |
|
03:55 PM - 04:15 PM |
What's New in the Management of Intracranial Hypertension
Michel T. Torbey, MD, MPH, FAAN |
|
04:15 PM - 04:35 PM |
What's New in the Management of Neuromuscular Disease in the Intensive Care Unit
William D. Freeman, MD, FAAN |
|
04:35 PM - 05:00 PM |
Questions and Audience Case Presentations
|
Stephan A. Mayer, MD | Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Braincool. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MaxQ AI. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Mayer has received stock or an ownership interest from Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care. |
Edward M. Manno, MD, FAAN | No disclosure on file |
Thomas P. Bleck, MD, FAAN | Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH. |
Daryl R. Gress, MD, FAAN | Dr. Gress has nothing to disclose. |
Gene Y. Sung, MD, MPH | The institution of Dr. Sung has received research support from NIH. |
Michel T. Torbey, MD, MPH, FAAN | Dr. Torbey has nothing to disclose. |
William D. Freeman, MD, FAAN | Dr. Freeman has nothing to disclose. |